Still Detox provides medically supervised MDMA (ecstasy/molly) addiction treatment for adults in Boca Raton, Florida. Our board-certified Medical Director and clinical team manage MDMA stabilization, serotonin depletion recovery, and the dual diagnosis complexity that almost always accompanies MDMA use disorder — in a private, 14-bed setting adjacent to Boca Regional Hospital. Call now for a confidential, same-day assessment.
Free & confidential — takes about 60 seconds
Joint Commission Accredited
Florida DCF Licensed
LegitScript Certified
Verified by Psychology TodayMDMA addiction is classified by the DSM-5 as stimulant use disorder — a chronic condition defined by compulsive MDMA use despite significant harm to health, relationships, or daily functioning. MDMA (3,4-methylenedioxymethamphetamine), sold as ecstasy or molly, is a synthetic entactogen that simultaneously floods the brain with serotonin, dopamine, and norepinephrine. The acute effects — emotional openness, empathy, euphoria, and stimulation — are driven primarily by a massive serotonin release that the brain cannot sustain. What follows is the comedown: a serotonin deficit state characterized by depression, exhaustion, anxiety, and cognitive difficulty that can last days.
NIDA confirms that some people develop compulsive MDMA use with tolerance, withdrawal symptoms, and significant functional impairment. Heavy or frequent use produces measurable serotonin system damage — research has shown reductions in serotonin transporter density in heavy MDMA users. MDMA addiction also presents a significant adulteration problem: many pills or powders sold as molly or ecstasy contain no actual MDMA, instead containing methamphetamine, bath salts, PMA, ketamine, or increasingly, fentanyl. Still Detox uses urine toxicology at admission to identify exactly what substances are present.
MDMA addiction operates through a different neurological pathway than other stimulants. Where cocaine and methamphetamine act primarily on dopamine, MDMA's primary mechanism is serotonin flooding — which is why its effects feel qualitatively different and why its withdrawal is characterized more by depression and emotional blunting than by the energetic crash of dopamine-driven stimulants. With repeated use, the brain's serotonin system is progressively depleted and, with heavy use, structurally damaged.
Unlike alcohol or benzodiazepine withdrawal, MDMA withdrawal does not carry a risk of medically dangerous seizures and does not require a chemical taper. Clients are admitted directly into monitored stabilization and residential care. The primary clinical challenges are psychological: severe post-use depression that can be prolonged after heavy use, potential serotonin syndrome risk if MDMA was combined with SSRIs or MAOIs, and the frequent presence of adulterants that change the clinical picture entirely.
The co-occurrence of MDMA use disorder with depression, anxiety, trauma, and PTSD is high. MDMA is often used to manage emotional pain, social anxiety, or relational disconnection — and stopping it without addressing those underlying conditions means the psychological drivers of use return in full force. Dual diagnosis treatment is not optional for this population; it is the clinical center of the residential program that follows stabilization.
MDMA use disorder presents a unique clinical picture — serotonin depletion, adulteration risk, and high rates of co-occurring depression and trauma. Still Detox addresses all of it from day one.
Our Medical Director, board-certified in addiction medicine, evaluates every client within 24 hours of admission. Urine toxicology identifies actual substances present — critical when street MDMA frequently contains methamphetamine, bath salts, or fentanyl rather than MDMA itself.
MDMA use disorder co-occurs with depression, anxiety, PTSD, and social anxiety at high rates. Still Detox evaluates and treats co-occurring conditions from the first clinical day — the serotonin depletion of MDMA withdrawal compounds underlying mood disorders in ways that require concurrent psychiatric management.
Located on the University Hospital campus, adjacent to Boca Regional Hospital. Emergency services are immediately accessible — especially important for clients presenting with adulterant-related complications or serotonin syndrome risk from MDMA combined with serotonergic medications.
Stabilization flows directly into inpatient residential treatment on the same campus. The emotional pain, social anxiety, or relational trauma that drove MDMA use is addressed in the therapeutic program that begins where stabilization ends.
Every team member, from behavioral health techs through the Medical Director, is fluent in English and Spanish. Complete MDMA addiction treatment services are available in Spanish.
Unlike most treatment facilities, Still Detox fully accommodates legitimate service animals during MDMA addiction treatment. Dogs and cats are welcome. Recovery should not require leaving your companion behind.
People come to Still Detox at their most vulnerable. Here is what they say about the care, the staff, and the recovery they found on the other side.
MDMA withdrawal is clinically distinct from stimulant withdrawal from cocaine or methamphetamine because its primary mechanism is serotonergic rather than dopaminergic. The MDMA high is driven by a massive, unsustainable serotonin release. What follows — the comedown — is the neurochemical inverse: a serotonin-depleted state that produces depression, emotional blunting, and fatigue rather than the energetic crash of purely dopaminergic stimulants.
The severity and duration of MDMA withdrawal depend on the frequency and quantity of use, whether the substance used was pure MDMA or adulterated, co-occurring psychiatric conditions, and individual serotonin system baseline. In occasional users, the comedown resolves in 1 to 3 days. In heavy frequent users, a more prolonged post-use syndrome resembling clinical depression can persist for weeks to months.
As MDMA clears the system, serotonin levels plummet below baseline. Fatigue, dysphoric mood, irritability, difficulty concentrating, and mild anxiety emerge. Many users describe a profound emotional flatness — the opposite of the connection and euphoria the drug produced. Physical symptoms include jaw clenching, muscle aches, headaches, and poor sleep.
Depression, emotional blunting, fatigue, hypersomnia, and anxiety are at their worst. Cognitive difficulty — confusion, poor memory consolidation, difficulty making decisions — is common and reflects the serotonin depletion driving the neurochemical state. Strong cravings for MDMA emerge as the brain attempts to correct the neurotransmitter deficit through the only mechanism it has learned to use.
For occasional users, most acute symptoms resolve by days 4 to 7. For heavy or frequent users, depression, anxiety, sleep disruption, and cognitive difficulty can persist throughout this window and beyond. If adulterated MDMA containing methamphetamine was used, the withdrawal profile shifts significantly — methamphetamine withdrawal follows its own timeline with different peak intensity and symptom profile.
Heavy long-term MDMA use can produce a post-use syndrome lasting weeks to months, characterized by persistent depression, anxiety, cognitive impairment, and sleep disruption. Research suggests this reflects lasting changes to serotonin transporter function in heavy users. Dual diagnosis treatment addressing co-occurring depression and anxiety is the evidence-based clinical response during this period.
Knowing what to expect removes one of the biggest barriers to asking for help. Here is how MDMA addiction treatment at Still Detox works from first call through residential care.
Your admissions representative gathers your MDMA use history, frequency of use, co-occurring conditions, and any other substances used. Out-of-network PPO benefits are verified before you commit. Travel and logistics are coordinated before your arrival.
A pre-admission call within three days of arrival covers your full substance use history, psychiatric history, and any co-occurring depression, anxiety, trauma, or PTSD — ensuring the dual diagnosis assessment is ready on day one.
A nurse and behavioral health tech meet you together for a structured intake. Urine toxicology is conducted at admission to identify actual substances present — critical given how frequently street MDMA contains methamphetamine, bath salts, or fentanyl rather than actual MDMA. No medical taper is required for MDMA withdrawal.
Within 24 hours, the Medical Director completes a full history and physical. Your psychiatric evaluation and dual diagnosis assessment are established based on your individual presentation, including screening for serotonin syndrome risk from MDMA combined with any serotonergic medications.
Vital signs monitored regularly. Comfort medications address insomnia, anxiety, depression, and any adulterant-related complications. Psychiatric monitoring throughout the comedown window. Typical stabilization stay is 7 to 10 days before stepping down to residential care.
Around day 8, you step directly into residential treatment on the same campus. The emotional pain, social anxiety, and underlying conditions driving MDMA use are addressed in the therapeutic program that begins where stabilization ends — without facility transfer or disruption.
The DSM-5 classifies MDMA addiction as stimulant use disorder using 11 diagnostic criteria. A diagnosis requires 2 or more criteria in a 12-month period. Mild is 2 to 3; moderate is 4 to 5; severe is 6 or more. MDMA's serotonergic mechanism gives its use disorder a distinct emotional and psychological character compared to dopamine-driven stimulants.
Using MDMA in larger amounts or more frequently than planned. Common among people who redose during the same session to extend the effect, or who use more frequently than intended to manage the coming depressive aftermath of prior use.
A persistent desire to reduce or stop MDMA use combined with repeated unsuccessful efforts. The cycle of use, comedown depression, and craving for the relief that only MDMA provides creates a psychological trap that is difficult to exit without clinical support.
Spending significant time obtaining MDMA, using it, or recovering from its effects. When the multi-day recovery cycle from each use session begins to consume work, relationships, and daily responsibilities, it signals significant disorder severity.
A strong urge to use MDMA, frequently emerging during the comedown when serotonin depletion produces depression and emotional pain that MDMA temporarily relieves. MDMA cravings are often emotionally contextual — triggered by social situations, loneliness, or trauma activation.
MDMA use and the multi-day recovery it requires interfering with work performance, family responsibilities, or daily obligations. The cognitive impairment and emotional blunting of prolonged comedowns erode functional capacity in ways that escalate with use frequency.
Persisting with MDMA use despite conflict with family members or partners caused or worsened by behavioral changes, emotional unavailability during comedowns, or the social environment associated with MDMA use — festivals, clubs, party circuits.
Giving up hobbies, relationships, or meaningful activities in favor of events or social contexts where MDMA is used. Life progressively reorganizes around the social circuit that facilitates use — at the cost of the broader relationships and interests that supported wellbeing.
Using MDMA while on SSRIs or MAOIs, which dramatically increases serotonin syndrome risk; combining with alcohol, cocaine, or ketamine; using in physically demanding environments without adequate hydration; or using adulterant-contaminated pills with unknown contents including fentanyl.
Persisting with MDMA use despite awareness of physical or psychological harm including worsening depression between uses, cognitive decline, sleep disruption, overheating episodes, and the documented serotonin system damage associated with heavy long-term MDMA use.
Requiring significantly higher MDMA doses to achieve the same empathogenic or euphoric effect. Tolerance to MDMA's serotonergic effects develops faster than tolerance to its stimulant effects, meaning users typically notice diminishing emotional impact before diminishing physical stimulation — requiring dose escalation to recapture the original experience.
Experiencing the MDMA comedown: depression, fatigue, hypersomnia, anxiety, difficulty concentrating, irritability, and muscle aches when MDMA clears the system. In heavy users, a more prolonged post-use syndrome resembling clinical depression confirms psychological dependence and marks a significant escalation in disorder severity.
Source: DSM-5 stimulant use disorder criteria. Any 2 or more in a 12-month period constitutes a diagnosis. If MDMA use has become difficult to control or is producing significant depression or harm, a clinical evaluation is the right next step.
Talk to Admissions ConfidentiallyThese are real before-and-after moments from people who completed treatment at Still Detox and built lasting sobriety. Each one reflects a brain that found genuine emotional connection, motivation, and peace — without a chemical catalyst.
Heavy or frequent MDMA use produces serotonin depletion that, in some individuals, extends into a clinical depression lasting weeks to months. For people with pre-existing depressive disorders, the post-MDMA serotonin deficit can trigger a severe depressive episode that includes suicidal ideation and requires active psychiatric monitoring — not just time and rest.
Most street MDMA contains adulterants including methamphetamine, synthetic cathinones, PMA, or fentanyl. Someone seeking help for MDMA addiction may actually be managing methamphetamine dependence, opioid dependence, or the cardiovascular complications of PMA exposure. Without toxicology at admission, the clinical picture is incomplete and the treatment is potentially misaligned.
MDMA is frequently used to manage depression, social anxiety, PTSD, or relational pain. Stopping MDMA without treating the underlying condition means those symptoms return — often intensified by the serotonin depletion of withdrawal — and the pressure to use resumes almost immediately. Dual diagnosis treatment is the clinical center of MDMA recovery, not an add-on.
Still Detox is an out-of-network provider for most insurance plans. Many clients with PPO plans that carry out-of-network benefits apply that coverage toward MDMA addiction treatment and residential care. Our admissions team verifies your specific benefits at no cost and with no obligation before admission.
We confirm what your plan covers, walk through any out-of-pocket responsibility, and explain flexible payment options including monthly payment plans and promissory arrangements. Cost should never be the reason someone does not receive MDMA addiction treatment.
Don't see your plan? Call us. Our specialists work with many coverage scenarios and will give you an honest answer about what is covered.
MDMA withdrawal leaves the serotonin system depleted. Our facility is designed to support natural neurotransmitter recovery through clinical care, nutrition, physical activity, and the social connection that MDMA users often sought in the drug itself.
Many clients seeking MDMA addiction treatment are actually managing dependence on methamphetamine, synthetic cathinones, or other adulterants in what was sold as molly. Still Detox uses urine toxicology at admission to identify the actual substances present and builds the clinical plan around the real pharmacological picture, not the assumed one.
MDMA is frequently used to manage depression, social anxiety, PTSD, or trauma. Still Detox treats co-occurring psychiatric conditions concurrently — integrated from the first clinical day — so that stopping MDMA does not mean returning to unmanaged psychological pain with no support structure.
MDMA use disorder is treatable. The depression, emotional pain, and exhaustion of the comedown cycle do not have to be the permanent rhythm of life. Our team is on-site 24 hours a day, same-day assessments are available now, and residential care that addresses the root causes of MDMA use begins right after stabilization.
We're here 24/7. Speak with admissions, confidentially and with no obligation.
☎ Call (561) 556-2677Accreditations & Memberships
We understand that there are no shortcuts on the path to recovery, and our compassionate team offers unwavering support and intensive care throughout your healing journey.
Still Detox is a member of Still Behavioral Health Group.
Get Help Now
If you or someone you care about is seeking support for substance abuse and addiction challenges, we are here to offer our assistance. This is where your journey towards healing begins.
© 2026 | Still Detox Drug and Alcohol Treatment Center in Florida
950 NW 9th CT, Boca Raton, FL 33486
